WNK4 kinase negatively regulates the surface expression of muscarinic M3 receptor

Woo Young Chung1, Hyun Woo Park, Dae Keon Heo

  • 1Department of Pharmacology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea.

Cellular Signalling
|December 2, 2010
PubMed

Insights

With-No-Lysine [K] 4 (WNK4) kinase regulates muscarinic receptor 3 (M₃R) surface expression. This regulation occurs independently of WNK4

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • With-No-Lysine [K] 4 (WNK4) kinase is crucial for regulating the plasma membrane expression of ion transporters.
  • Proper cell surface expression of G-protein coupled receptors (GPCRs), like muscarinic receptor 3 (M₃R), is essential for their function.

Purpose of the Study:

  • To investigate the role of WNK4 kinase in modulating the surface expression and activity of muscarinic receptor 3 (M₃R).
  • To elucidate the mechanism by which WNK4 kinase affects M₃R trafficking and function.

Main Methods:

  • Physiological experiments measuring pilocarpine-induced intracellular calcium ([Ca(2+)](i)) changes.
  • Biochemical assays including surface biotinylation and immunostaining.
  • Analysis of M₃R total and surface protein half-life.
  • Utilized wild-type and kinase-inactive WNK4 mutants (WNK4(D318A)) and WNK4 fragments.

Main Results:

  • WNK4 kinase significantly reduces M₃R activity, correlating with decreased surface expression.
  • The interaction between WNK4 kinase domain and M₃R's third intracellular region is key, but regulation is independent of WNK4's kinase activity.
  • Both wild-type and kinase-inactive WNK4 mutants reduced M₃R surface expression, while a WNK4 fragment lacking the kinase domain did not.
  • WNK4 decreases the half-life of total M₃R but not surface M₃R, indicating accelerated degradation of total M₃R.
  • The rate of decrease in surface M₃R exceeded that of total M₃R, suggesting impaired anterograde trafficking.

Conclusions:

  • WNK4 kinase negatively regulates M₃R surface expression and activity through a kinase-independent mechanism.
  • WNK4 appears to inhibit the anterograde trafficking of M₃R to the plasma membrane.
  • These findings highlight a novel regulatory pathway for GPCR surface expression involving WNK4.

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...